Insurance Coverage

Out-of-Pocket Expenses Patient Expenses Family Contributions Employer Responsibilities Medications Assistive Devices Medicare and Medicaid Medicaid Cash-Pay Patients Drug Pricing Patient Fees Consumer Spending Long-term Care Financing

10 ARTICLES

last mo.

Generics and Pills Expand Access to GLP‑1s, but Uptake and Coverage Remain Uneven

New oral drugs and cheaper generics are driving interest while cost, injection aversion, uncertain long‑term effects and high payer bills are prompting cautious prescribing and tighter employer coverage.

9 ARTICLES

9mo ago

White House Finalizes GLP-1 Price Deal With Lilly and Novo, Setting $50 Medicare Copays

3 ARTICLES

last yr.

Senator Maggie Hassan Launches Probe of GSK’s Pediatric Asthma Inhaler Switch